Delivery Order SPE2DR25D2104-SPE2DR26F3SNN
- Not listed
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $8,732.28 for 60 tablets of Briviacta 50 mg by the Defense Logistics Agency on November 18, 2025. This non-set-aside contract employs firm fixed pricing and carries an ultimate completion date of November 19, 2025. The delivery order is being fulfilled from the company's place of performance in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on September 25, 2025, for 60 tablets of Briviact 100 mg with a ceiling value of $3,985.20. This firm fixed-price, non-set-aside delivery order is scheduled for completion by September 26, 2025, and represents a specific pharmaceutical supply need within the federal medical procurement system. The award is performed at the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Briviact 100 mg tablets (60-count) with a ceiling value of $5,575.90. This delivery order, issued on December 11, 2025, with an ultimate completion date of December 12, 2025, carries firm fixed-price terms and represents a non-set-aside competitive award. The place of performance is located in Conshohocken,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on October 20, 2025, for Briviact 75 mg tablets (60-count packages) valued at $2,183.46. This is a competitively awarded, firm fixed-price delivery order with no set-aside designation and an ultimate completion date of October 21, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $5,394.54 delivery order to AmerisourceBergen Drug Corp for Briviact 100mg tablets (60 count) on December 4, 2025, with completion expected by December 5, 2025. This non-competitive, firm fixed-price delivery order represents a single pharmaceutical product shipment to support federal medical supply needs. The award was performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a...
- The Defense Logistics Agency awarded a delivery order valued at $5,677.12 to AmerisourceBergen Drug Corp for the supply of Briviact 100 mg tablets (60-count units) on August 18, 2025, with an ultimate completion date of August 19, 2025. This competitive, non-set-aside award employs firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026....
- AmerisourceBergen Drug Corp was awarded a delivery order on September 4, 2025, by the Defense Logistics Agency (DLA) for 60 tablets of Briviact 100 mg, with a contract value of $1,041.97 and an ultimate completion date of September 5, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a tactical pharmaceutical supply fulfillment under DLA's...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Briviact 50 mg tablets in a 60-count package. This competitively awarded, firm fixed-price delivery order has a ceiling value of $6,025.11 and was awarded on October 27, 2025, with an ultimate completion date of October 28, 2025. The award was executed without a set-aside designation, demonstrating...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Briviact 100 mg tablets (60-count) valued at $5,205.36 under a firm fixed-price contract. The award was made on December 11, 2025, with an ultimate completion date of December 12, 2025, and does not include a set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. This delivery order is issued under the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $7,332.63 under a firm fixed-price contract for Briviact 50 mg tablets (60-count supply). The award was issued on December 16, 2025, with an ultimate completion date of December 17, 2025, and represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's...
- SPE2DR25D2104Indefinite Delivery Contract
- SPE2DR25D2104-SPE2DR26F3SNNDelivery Order
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a Delivery Order award (Contract No. 4570376263) from the Defense Logistics Agency for the supply of Briviact 25 mg tablets (60-count). This firm fixed-price delivery order, valued at $5,406.06, represents a non-set-aside competitive award with an ultimate completion date of December 31, 2025. The award was issued on December 30, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As the prime contractor on this comprehensive global pharmaceutical support vehicle, AmerisourceBergen Drug Corp supplies an extensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard. The company's demonstrated capability to meet federal medical procurement requirements through open competition, combined with its broad pharmaceutical portfolio spanning specialty medications, brand-name and generic drugs, and vaccines, positions it as a critical vendor for federal medical supply needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.4k | 12/29/25 |